Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

PProtalix BioTherapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
P

Protalix BioTherapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • History
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

No buy/sell activity
DateNameTitleSharesValueTransactionSource
Sep 3, 2026Schwartz AharonDirector8,500Restricted Stock Units—Grant / award
Sep 3, 2026Schwartz AharonDirector17,000Stock Options (Right to Buy)—Grant / award
Sep 3, 2026Bar-Shalev AmosDirector8,500Restricted Stock Units—Grant / award
Sep 3, 2026Bar-Shalev AmosDirector17,000Stock Options (Right to Buy)—Grant / award
Sep 3, 2026Boudes Pol FDirector8,500Restricted Stock Units—Grant / award
Sep 3, 2026Boudes Pol FDirector17,000Stock Options (Right to Buy)—Grant / award
Sep 3, 2026Melincoff Gwen ADirector8,500Restricted Stock Units—Grant / award
Sep 3, 2026Melincoff Gwen ADirector17,000Stock Options (Right to Buy)—Grant / award
Sep 3, 2026Naos YaronSr. VP & COO56,000Restricted Stock Units—Grant / award
Sep 3, 2026Naos YaronSr. VP & COO112,000Stock Option (Right to Buy)—Grant / award
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • History
  • Insider Transactions